Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Weizman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Suicide & Life-Threatening Behavior|October 2, 2009
Association between terror attacks and suicide attemptsTal Weizman, Yaron Yagil, Shaul Schreiber
The Israel Journal of Psychiatry and Related Sciences|September 14, 2002
Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approachAvi Bleich, Marc Gelkopf, Tal Weizman, et al.
The Australian and New Zealand Journal of Psychiatry|July 23, 2003
Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidityTal Weizman, Marc Gelkopf, Yuval Melamed, et al.
The Australian and New Zealand Journal of Psychiatry|January 21, 2004
Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinicTal Weizman, Marc Gelkopf, Yuval Melamed, et al.
The Israel Journal of Psychiatry and Related Sciences|August 17, 2006
Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinicMarc Gelkopf, Tal Weizman, Yuval Melamed, et al.
European Journal of Pharmacology|October 25, 2003
The antinociceptive effect of amisulpride in mice is mediated through opioid mechanismsTal Weizman, Chaim G Pick, Maria M Backer, et al.
Nature|September 4, 2024
Engineered T cell therapy for central nervous system injuryWenqing Gao, Min Woo Kim, Taitea Dykstra, et al.
Nature|March 5, 2025
Cell-autonomous innate immunity by proteasome-derived defence peptidesKarin Goldberg, Arseniy Lobov, Paola Antonello, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Suicide & Life-Threatening Behavior|October 2, 2009
Association between terror attacks and suicide attemptsTal Weizman, Yaron Yagil, Shaul Schreiber
The Israel Journal of Psychiatry and Related Sciences|September 14, 2002
Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approachAvi Bleich, Marc Gelkopf, Tal Weizman, et al.
The Australian and New Zealand Journal of Psychiatry|July 23, 2003
Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidityTal Weizman, Marc Gelkopf, Yuval Melamed, et al.
The Australian and New Zealand Journal of Psychiatry|January 21, 2004
Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinicTal Weizman, Marc Gelkopf, Yuval Melamed, et al.
The Israel Journal of Psychiatry and Related Sciences|August 17, 2006
Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinicMarc Gelkopf, Tal Weizman, Yuval Melamed, et al.
European Journal of Pharmacology|October 25, 2003
The antinociceptive effect of amisulpride in mice is mediated through opioid mechanismsTal Weizman, Chaim G Pick, Maria M Backer, et al.
Nature|September 4, 2024
Engineered T cell therapy for central nervous system injuryWenqing Gao, Min Woo Kim, Taitea Dykstra, et al.
Nature|March 5, 2025
Cell-autonomous innate immunity by proteasome-derived defence peptidesKarin Goldberg, Arseniy Lobov, Paola Antonello, et al.
Pageof 1